Health
Diagnostic, therapeutic advance for rare neurodegenerative disorder – Medical Xpress
Mayo Clinic researchers, along with national and global collaborators, have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type…
Mayo Clinic researchers, along with national and global collaborators, have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3)a disease that has no cure. They also have clarified the role of a gene target associated with the disease.
The inherited disease is linked to a mutation in the ATXN3 gene. This mutation, which affects the central nervous system, appears between the ages of 40 and 70, and is characterized by an unsteady gait, loss of muscle control,…
-
Noosa News23 hours agoYoung voices shape Sunshine Coast’s future
-
Business23 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News22 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News23 hours agoSunshine Coast police disappointed by drink drivers in school zone